Business
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead
MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange Admission follows successful IPO for $11.6m from sophisticated and…
Link copied toclipboard
- MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
- Admission follows successful IPO for $11.6m from sophisticated and institutional investors
- Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors
The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…
Continue Reading
-
General18 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
Business18 hours agoHere’s the average Australian superannuation balance at age 60
-
General13 hours agoCoomalie council dismissed by NT government after investigation finds ‘serious deficiencies’
-
Noosa News20 hours agoOpinion: What is a good decision?